Form 4 for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001801170-24-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-01 | CLOV | Toy Andrew | CEO, Dir | F - Tax | $0.77 | -308.3K | 10.59M | -3% | -$237.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-04-01 | F | D | 308,341 | $0.77 | 10,589,737 | D | — | — | (F1) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 1, 2024, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. |